[1] Huang C, Zhu H L, Xu K R, et al. Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta-analysis[J]. Andrology, 2015, 3(5):809-816.
[2] Volgmann T, Ohlinger R, Panzig B. Ureaplasma urealyticum-harmless commensal or underestimated enemy of human reproduction? A review[J]. Archives of Gynecology & Obstetrics, 2005, 273(3):133-139.
[3] Edwards S. Sexually Transmitted Diseases: Advances in Diagnosis and Treatment[J]. Advances in Internal Medicine, 1994, 39(3):149.
[4] Xie Q Z, Wang-Ming X U, Qian-Rong Q I, et al. Patients with Cervical Ureaplasma Urealyticum and Chlamydia Trachomatis Infection Undergoing IVF/ICSI-ET: The Need for New Paradigm[J]. J Huazhong Univ Sci Technolog Med Sci, 2016, 36(5):716-722.
[5] Ziklo N, Huston WM, Hocking JS, et al. Chlamydia trachomatis Genital Tract Infections: When Host Immune Response and the Microbiome Collide[J]. Trends in Microbiology,2016,24(9):750-765.
[6] Verteramo R, Patella A, Calzolari E, et al. An epidemiological survey of Mycoplasma hominis and Ureaplasma urealyticum in gynaecological outpatients, Rome, Italy[J]. Epidemiology and Infection,2013,141(12):2650-2657.
[7] Tomusiak A, Heczko P B, Janeczko J, et al. Bacterial infections of the lower genital tract in fertile and infertile women from the southeastern Poland[J]. Ginekologia Polska, 2013, 84(5):352-358.
[8] Sleha R, Boštíková V, Hampl R, et al. Prevalence of Mycoplasma hominis and Ureaplasma urealyticum in women undergoing an initial infertility evaluation[J]. Epidemiol Mikrobiol Imunol, 2016, 65(4):232-237.
[9] Qing L, Song QX, Feng JL,et al. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Ureaplasma urealyticum infections using a novel isothermal simultaneous RNA amplification testing method in infertile males[J]. Ann Clin Microbiol Antimicrob. 2017, 16(1):45.
[10] Zhou YH, Ma HX, Shi XX,et al. Ureaplasma spp. in male infertility and its relationship with semen quality and seminal plasma components[J]. J Microbiol Immunol Infect. 2017,S1684-1182(17)30071-30073.
[11] Wang Y, Wu ZW, Zhang LF, et al. Effects of Ureaplasma urealyticum infection on the male reproductive system in experimental rats[J]. Andrologia, 2010,42(5):297-301.
[12] Newman L, Rowley J, Vander Hoorn S, et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting[J]. PLOS ONE,2015,10(12):e143304.
[13] Hansen BT, Kjaer SK, Arnheim-Dahlström L, et al. Age at first intercourse, number of partners and STI prevalence among Danish, Norwegian and Swedish women: estimates and trends from nationally representative cross-sectional surveys of more than 100 000 women.
[14] Sexually transmitted infections and chlamydia screening in England, 2015[R]. Health Protection Report Vol 10 No. 22 -8 July 2016 (Republished 11 October 2016.)
[15] Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial[J]. Bmj, 2008, 9(1):1-6.
[16] Carne CA, Gibbs J, Delaney A, et al. Prevalence, clinical features and quantification of genital non-viral infections[J]. International Journal of STD & AIDS,2013,24(4):273-277.
[17] Song T, Ye A, Xie X, et al. Epidemiological investigation and antimicrobial susceptibility analysis of ureaplasma species and Mycoplasma hominis in outpatients with genital manifestations[J]. Journal of Clinical Pathology, 2014, 67(9):817-820.
[18] Abusarah EA, Awwad ZM, Charvalos E, et al. Molecular detection of potential sexually transmitted pathogens in semen and urine specimens of infertile and fertile males[J]. Diagnostic Microbiology and Infectious Disease,2013,77(4):283-286.
[19] He M, Xie Y, Zhang R, et al. Prevalence and antimicrobial resistance of Mycoplasmas and Chlamydiae in patients with genital tract infections in Shanghai, China[J]. Journal of Infection and Chemotherapy,2016,22(8):548-552.
[20] Luo Z, Li W, Wu Q, et al. Population-based study of chlamydial and gonococcal infections among women in Shenzhen, China: Implications for programme planning[J]. PLOS ONE,2018,13(5):e196516.
[21] Huang C, Long X, Jing S, et al. Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China[J]. World Journal of Urology,2016,34(7):1039-1044.
[22] Zhu X, Li M, Cao H, et al. Epidemiology of Ureaplasma urealyticum and Mycoplasma hominis in the semen of male outpatients with reproductive disorders[J]. Experimental & Therapeutic Medicine, 2016, 12(2):1165.
[23] http://www.stats.gov.cn/tjsj/zxfb/201802/t20180228_1585631.html[EB/OL]
[24] IvanWolffers, IreneFernandez, SharunaVerghis, et al. Sexual behaviour and vulnerability of migrant workers for HIV infection[J]. Culture Health & Sexuality, 2002, 4(4):459-473.
[25] Tiruneh K, Wasie B, Gonzalez H. Sexual behavior and vulnerability to HIV infection among seasonal migrant laborers in Metema district, northwest Ethiopia: a cross-sectional study[J]. BMC Public Health,15,1(2015-02-11), 2015, 15(1):1-10.
[26] Dai W, Gao J, Gong J, et al. Sexual behavior of migrant workers in Shanghai, China.[J]. BMC Public Health, 2015, 15(1):1067.
[27] Wang W, Wei C, Buchholz ME, et al. Prevalence and risks for sexually transmitted infections among a national sample of migrants versus non-migrants in China[J]. International Journal of STD & AIDS,2010,21(6):410-415.
[28] Wang L, Jin L, Xiong W, et al. Infectious Disease Surveillance in China[M]// Early Warning for Infectious Disease Outbreak. 2017.
[29] Xiang Z, Yin YP, Shi MQ, et al. Risk factors for Mycoplasma genitalium infection among female sex workers: a cross-sectional study in two cities in southwest China[J]. BMC Public Health,2012,12:414.
[30] Song Y, Li X, Zhang L, et al. HIV testing behavior among young migrant men who have sex with men (MSM) in Beijing, China[J]. Aids Care, 2011, 23(2):179-186.
[31] Zheng Q, Liu W, Zhang G W, et al. RNA simultaneous and amplification testing versus the culture method for detecting Ureaplasma urealyticum infection[J]. National Journal of Andrology, 2017, 23(8):717.
[32] Sviben M, Ljubinsternak S, Meštrović T, et al. Sociodemographic, Sexual Behavior, and Microbiological Profiles of Men Attending Public Health Laboratories for Testing for Sexually Transmitted Diseases[J]. Acta Dermatovenerologica Croatica Adc, 2017, 25(2):125.
[33] Kucinskiene V, Sutaite I, Valiukeviciene S, et al. Prevalence and risk factors of genital Chlamydia trachomatis infection[J]. Medicina, 2006, 42(11):885-894.
[34] Wetmore C M, Manhart L E, Lowens M S, et al. Demographic, Behavioral, and Clinical Characteristics of Men With Nongonococcal Urethritis Differ by Etiology: A Case-Comparison Study[J]. Sexually Transmitted Diseases, 2011, 38(3):180.
[35] Berle L M, Firsova N, Kalashnik A, et al. Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum in clinical and non-clinical settings, Arkhangelsk Oblast, Russia[J]. International Journal of Std & Aids, 2012, 23(11):781-784.
[36] Balamurugan S, Bendigeri ND. Community-based study of reproductive tract infections among women of the reproductive age group in the urban health training centre area in Hubli, Karnataka[J]. Indian Journal of Community Medicine,2012,37(1):34.
[37] Kim Y, Kim J, Lee K A. Prevalence of sexually transmitted infections among healthy Korean women: implications of multiplex PCR pathogen detection on antibiotic therapy[J]. Journal of Infection & Chemotherapy, 2014, 20(1):74-76.
[38] Anand E, Singh J, Unisa S. Menstrual hygiene practices and its association with reproductive tract infections and abnormal vaginal discharge among women in India[J]. Sexual & Reproductive Health care,2015,6(4):249-254.
[39] Silva J, Cerqueira F, Teixeira A L, et al. Genital mycoplasmas and ureaplasmas in cervicovaginal self-collected samples of reproductive-age women: prevalence and risk factors.[J]. International Journal of Std & Aids, 2018:095646241877420.
[40] Parish W L, Laumann E O, Cohen M S, et al. Population-based study of chlamydial infection in China: a hidden epidemic[J]. Jama the Journal of the American Medical Association, 2003, 289(10):1265-1273.
[41] Zhu Y, Yin B, Wu T, et al. Comparative study in infertile couples with and without Chlamydia trachomatis genital infection[J]. Reproductive Health,2017,14:5.
[42] Lopez L M, Otterness C, Chen M, et al. Behavioral interventions for improving condom use for dual protection[M]// The Cochrane Library. John Wiley & Sons, Ltd, 2013:CD010662.
[43] Paz-Bailey G , Koumans E H , Sternberg M , et al. The Effect of Correct and Consistent Condom Use on Chlamydial and Gonococcal Infection Among Urban Adolescents[J]. Archives of Pediatrics & Adolescent Medicine, 2005, 159(6):536.
[44] Hood J E, Hogben M, Chartier M, et al. Dual contraceptive use among adolescents and young adults: correlates and implications for condom use and sexually transmitted infection outcomes[J]. J Fam Plann Reprod Health Care, 2014, 40(3):200-207.
[45] Demirbag BC, Köksal I, Kaya S. Genitourinary infection prevalence among women who used an intrauterine device or oral contraceptives[J]. Archives of Gynecology and Obstetrics,2013,288(4):911-916.
[46] Horner P, Donders G, Cusini M, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and U. urealyticum in men and women? - a Position Statement from the European STI Guidelines Editorial Board[J]. J Eur Acad Dermatol Venereol. 2018 Jun 20. doi: 10.1111/jdv.15146.